Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 76, 2021 - Issue 2
290
Views
4
CrossRef citations to date
0
Altmetric
Article

Factors associated with the number of clinical pharmacy recommendations: findings from an observational study in geriatric inpatients

ORCID Icon, ORCID Icon, , , ORCID Icon, & show all

References

  • Christensen M, Lundh A. Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database Syst Rev. 2016;2:Cd008986.
  • Clyne B, Fitzgerald C, Quinlan A, et al. Interventions to address potentially inappropriate prescribing in community-dwelling older adults: a systematic review of randomized controlled trials. J Am Geriatr Soc. 2016;64(6):1210–1222.
  • Petrovic M, Somers A, Onder G. Optimization of geriatric pharmacotherapy: role of multifaceted cooperation in the hospital setting. Drugs Aging. 2016;33(3):179–188.
  • Spinewine A, Fialova D, Byrne S. The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging. 2012;29(6):495–510.
  • Gray SL, Hart LA, Perera S, et al. Meta-analysis of interventions to reduce adverse drug reactions in older adults. J Am Geriatr Soc. 2018;66(2):282–288.
  • Scullin C, Scott MG, Hogg A, et al. An innovative approach to integrated medicines management. J Eval Clin Pract. 2007;13(5):781–788.
  • Johansen JS, Havnes K, Halvorsen KH, et al. Interdisciplinary collaboration across secondary and primary care to improve medication safety in the elderly (IMMENSE study): study protocol for a randomised controlled trial. BMJ Open. 2018;8(1):e020106.
  • Hellstrom LM, Bondesson A, Hoglund P, et al. Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits. Eur J Clin Pharmacol. 2011;67(7):741–752.
  • Renaudin P, Boyer L, Esteve MA, et al. Do pharmacist-led medication reviews in hospitals help reduce hospital readmissions? A systematic review and meta-analysis. Br J Clin Pharmacol. 2016;82(6):1660–1673.
  • Ravn-Nielsen LV, Duckert ML, Lund ML, et al. Effect of an in-hospital multifaceted clinical pharmacist intervention on the risk of readmission: a randomized clinical trial. J JAMA Int Med. 2018;178(3):375–382.
  • Van der Linden L, Decoutere L, Walgraeve K, et al. Combined use of the rationalization of home medication by an adjusted STOPP in older patients (RASP) list and a pharmacist-led medication review in very old inpatients: impact on quality of prescribing and clinical outcome. Drugs Aging. 2017;34(2):123–133.
  • Walgraeve K, Van der Linden L, Flamaing J, et al. Feasibility of optimizing pharmacotherapy in heart failure patients admitted to an acute geriatric ward: role of the clinical pharmacist. Eur Geriatric Med. 2018;9(1):103–111.
  • Pellegrin KL, Krenk L, Oakes SJ, et al. Reductions in medication-related hospitalizations in older adults with medication management by hospital and community pharmacists: a quasi-experimental study. J Am Geriatr Soc. 2017;65(1):212–219.
  • Van der Linden L, Hias J, Walgraeve K, et al. Clinical pharmacy services on geriatric care wards: catch 22 of implementation and research. Drugs Aging. 2018;35(5):375–377.
  • Somers A, Spinewine A, Spriet I, et al. Development of clinical pharmacy in Belgian hospitals through pilot projects funded by the government. Acta Clin Belg. 2019;74(2):75–81.
  • De Winter S, Vanbrabant P, Spriet I, et al. A simple tool to improve medication reconciliation at the emergency department. Eur J Intern Med. 2011;22(4):382–385.
  • Van der Linden L, Hias J, Spriet I, et al. Medication review in older adults: importance of time to benefit. Am J Health Syst Pharm. 2019;76(4):247–250.
  • American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. Guiding principles for the care of older adults with multimorbidity: an approach for clinicians. J Am Geriatr Soc. 2012;60(10):E1–E25.
  • Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med. 2010;170(18):1648–1654.
  • Braekhus A, Laake K, Engedal K. The mini-mental state examination: identifying the most efficient variables for detecting cognitive impairment in the elderly. J Am Geriatr Soc. 1992;40(11):1139–1145.
  • Jaeschke R, Guyatt GH, Sackett DL. Users’ guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The evidence-based medicine working group. JAMA. 1994;271(9):703–707.
  • El Hajji FW, Scullin C, Scott MG, et al. Enhanced clinical pharmacy service targeting tools: risk-predictive algorithms. J Eval Clin Pract. 2015;21(2):187–197.
  • Falconer N, Barras M, Cottrell N. Systematic review of predictive risk models for adverse drug events in hospitalized patients. Br J Clin Pharmacol. 2018;84(5):846–864.
  • Ponikowski P, Voors AA, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891–975.
  • Lee SJ, Kim CM. Individualizing prevention for older adults. J Am Geriatr Soc. 2018;66(2):229–234.
  • Somers A, Robays H, De Paepe P, et al. Evaluation of clinical pharmacist recommendations in the geriatric ward of a Belgian university hospital. Clin Interv Aging. 2013;8:703–709.
  • De Bock L, Tommelein E, Baekelandt H, et al. The introduction of a full medication review process in a local hospital: successes and barriers of a pilot project in the geriatric ward. Pharmacy (Basel). 2018;6(1):21.
  • Somers A, Claus B, Vandewoude K, et al. Experience with the implementation of clinical pharmacy services and processes in a university hospital in Belgium. Drugs Aging. 2016;33(3):189–197.
  • Ryan C, Ross S, Davey P, et al. Prevalence and causes of prescribing errors: the PRescribing outcomes for trainee doctors engaged in clinical training (PROTECT) study. PLoS One. 2014;9(1):e79802.
  • Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827–834.
  • Wauters M, Elseviers M, Vaes B, et al. Too many, too few, or too unsafe? Impact of inappropriate prescribing on mortality, and hospitalization in a cohort of community-dwelling oldest old. Br J Clin Pharmacol. 2016;82(5):1382–1392.
  • Tavernier R, Wolf M, Kataria V, et al. Screening for atrial fibrillation in hospitalised geriatric patients. Heart. 2018;104(7):588–593.
  • Kempen TGH, Bertilsson M, Lindner KJ, et al. Medication reviews bridging healthcare (MedBridge): study protocol for a pragmatic cluster-randomised crossover trial. Contemp Clin Trials. 2017;61:126–132.
  • Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.